Wellcome Genome Campus Development Limited
14378001
Some Concerns
- No accounts filed in last 18 months (-5)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
30/09/2025
small
Next accounts due
30/06/2027
Confirmation statement
Last: 26/09/2025
Due 10/10/2026
Industry
Officers
director · Since 01/06/2025
CHAIRMAN, INVESTMENT MANAGEMENT
BRITISH · UNITED KINGDOM · Age 61
Also on 25 other boards
director · Since 01/06/2025
CHIEF EXECUTIVE OFFICER
BRITISH · UNITED KINGDOM · Age 55
Also on 19 other boards
director · Since 06/11/2025
DIRECTOR
BRITISH · ENGLAND · Age 58
Also on 3 other boards
director · Since 06/11/2025
DIRECTOR
BRITISH · UNITED KINGDOM · Age 43
Also on 8 other boards
Persons with Significant Control
Wellcome Genome Campus Holdings Limited
Biodata Innovation Centre, Wellcome Genome Campus, Cambridge, CB10 1DR
Reg: 15739384 · Companies House · Limited By Shares
Notified 01/06/2025
Former PSCs
Urban&Civic Group Limited
Ceased 01/06/2025
CompanyRankvs 347980+ SIC 68320 peers37
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 30/09/2024
Turnover
£3.5M
Annual revenue
Net Worth
£2.1M
Balance sheet strength
Cash
—
Cash in the bank
Profit Before Tax
£584k
Bottom line earnings
Net Current Assets
£2.1M
Working capital
Current Assets
—
Current Liabilities
£8.1M
Debtors
£10.2M
Gross Profit
£3.5M
Admin Expenses
£3.1M
Operating Profit
£431k
Profit After Tax
£584k
Balance Sheet